The New York Society of Security Analysts, a leading forum for the investment community, recently announced the presenter list for its 14th Annual Biotech and Specialty Pharma Conference.
Blood Tests Can Enable Early Cancer Diagnosis
Scientists have yet to find the magic cure for cancer, but they may have found a way to beat it at its own game.
Molecular Diagnostics a Natural Fit for Breast Cancer
The growing global incidence of breast cancer has led to an increased demand for molecular diagnostics tests that aid in diagnosing breast cancer.
Luminex Corp. Launches Its First Pharmacogenomics Test for Personalized Medicine
Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.
New Study: Robot-Assisted Hysterectomy Offers Similar (But Pricier) Results Compared to Laparoscopic Counterpart
According to the National Institutes of Health, one in three women in the U.S. will undergo a hysterectomy by the age of 60.
Oncology Drugs Experience Sales Slowdown In U.S.
Cancer drug sales are slowing down in the U.S., Reuters reported Monday.
Advanced Life Sciences Announces Two New Achievements
Advanced Life Sciences (OTC BB: ADLS) took two steps this week toward advancing its lead drug candidate, Restanza.
Cytori Therepeutics Featured in Wired Magazine
Wired magazine recently published a feature on Cytori Therapeutics, a regenerative medicine company based in San Diego that is using stem and regenerative stem cells derived from fat (adipose) tissue to repair breasts disfigured by mastectomies and lumpectomies.
